Showing results (1-10 of 432) with videos related to

Sort By:
Pageof 44
American Journal of Respiratory and Critical Care Medicine|May 10, 2013
Phosphodiesterase-4 inhibitor therapy for lung diseasesBianca Beghè, Klaus F Rabe, Leonardo M Fabbri
International Journal of Chronic Obstructive Pulmonary Disease|July 14, 2012
Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? The REACT study protocolPeter M A Calverley, Fernando J Martinez, Leonardo M Fabbri, et al.
Chest|November 29, 2012
Seasonal distribution of COPD exacerbations in the Prevention of Exacerbations with Tiotropium in COPD trialKlaus F Rabe, Leonardo M Fabbri, Claus Vogelmeier, et al.
Respiratory Medicine|October 30, 2012
Effect of tiotropium vs. salmeterol on exacerbations: GOLD II and maintenance therapy naïve patientsClaus Vogelmeier, Leonardo M Fabbri, Klaus F Rabe, et al.
Lancet (London, England)|September 1, 2009
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsPeter M A Calverley, Klaus F Rabe, Udo-Michael Goehring, et al.
Respiratory Research|October 31, 2013
Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trialKai M Beeh, Thomas Glaab, Susanne Stowasser, et al.
Lancet (London, England)|February 17, 2015
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trialFernando J Martinez, Peter M A Calverley, Udo-Michael Goehring, et al.
The Lancet. Respiratory Medicine|January 28, 2014
Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trialKlaus F Rabe, Leonardo M Fabbri, Elliot Israel, et al.
The Lancet. Respiratory Medicine|December 11, 2013
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trialAlberto Papi, Massimo Corradi, Catherine Pigeon-Francisco, et al.
The European Respiratory Journal|September 8, 2018
Inhaled corticosteroids in COPD: friend or foe?Alvar Agusti, Leonardo M Fabbri, Dave Singh, et al.
Pageof 44